First Author | Cha HN | Year | 2010 |
Journal | Exp Gerontol | Volume | 45 |
Issue | 9 | Pages | 711-8 |
PubMed ID | 20493940 | Mgi Jnum | J:164264 |
Mgi Id | MGI:4830961 | Doi | 10.1016/j.exger.2010.05.004 |
Citation | Cha HN, et al. (2010) Lack of inducible nitric oxide synthase does not prevent aging-associated insulin resistance. Exp Gerontol 45(9):711-8 |
abstractText | Inducible nitric oxide synthase (iNOS) is involved in obesity-induced insulin resistance. Since aging is accompanied by increased iNOS expression, the effect of iNOS gene deletion on aging-associated insulin resistance was investigated in 7-month-old (adult) and 22-month-old (old) iNOS knockout and wild-type mice using the hyperinsulinemic-euglycemic clamp. While body weight and fat mass were increased, muscle mass was reduced with aging in wild-type mice. However, body composition was not changed with aging in iNOS knockout mice due to increased locomotor activity. NO metabolites in plasma, and protein levels of iNOS and nitrotyrosine in skeletal muscle increased with aging in wild-type mice. Deletion of iNOS gene attenuated NO metabolites and nitrotyrosine with aging in iNOS knockout mice. Glucose uptake in whole body and skeletal muscle was reduced with aging in both wild-type and iNOS knockout mice and there was no difference between two groups. Plasma level of tumor necrosis factor-alpha and gene expression of proinflammatory cytokines in peripheral tissues were increased with aging in both groups, and that was more heightened in iNOS knockout mice. These results suggest that lack of iNOS does not prevent aging-associated insulin resistance in mice and heightened production of proinflammatory cytokines may be involved. |